Hodgkin Disease Recurrent
Showing 1 - 2 of 2
Classical Hodgkin Lymphoma, Hodgkin Disease Refractory, Hodgkin Disease Recurrent Trial in United States (Nivolumab, Autologous
Recruiting
- Classical Hodgkin Lymphoma
- +2 more
- Nivolumab
- +3 more
-
Duarte, California
- +4 more
Jun 27, 2022
Hodgkin Lymphoma, Adult, Hodgkin Disease Recurrent, Hodgkin Disease Refractory Trial in United States (CD30.CAR-T, Fludarabine,
Active, not recruiting
- Hodgkin Lymphoma, Adult
- +3 more
- CD30.CAR-T
- +2 more
-
Duarte, California
- +4 more
Apr 3, 2022